STOCK TITAN

Anterix (ATEX) legal chief exercises 29,368 options, sells 17,711 shares

Filing Impact
(Very High)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

Anterix Inc. Chief Legal Officer & Corporate Secretary Gena L. Ashe exercised stock options and sold common stock in a series of transactions dated June 15, 2026. She exercised options covering 29,368 shares of common stock at strike prices of $34.96 and $49.39 per share.

To pay the exercise prices and related taxes on a cashless basis, the issuer withheld a total of 15,657 shares at $82.50 per share, which the filing clarifies did not involve open‑market sales. Ashe also completed open‑market sales totaling 17,711 shares at weighted average prices of about $81.04 and $82.14 per share. One reported sale left her with 9,531 shares held directly.

Positive

  • None.

Negative

  • None.
Insider Ashe Gena L
Role Chief Legal Officer & Corp Sec
Sold 17,711 shs ($1.44M)
Type Security Shares Price Value
Exercise Stock Option (Right to Buy) 11,000 $0.00 --
Exercise Stock Option (Right to Buy) 18,368 $0.00 --
Exercise Common Stock 11,000 $34.96 $385K
Exercise Common Stock 18,368 $49.39 $907K
Tax Withholding Common Stock 4,661 $82.50 $385K
Tax Withholding Common Stock 10,996 $82.50 $907K
Sale Common Stock 13,375 $81.0385 $1.08M
Sale Common Stock 4,336 $82.14 $356K
Holdings After Transaction: Stock Option (Right to Buy) — 42,491 shares (Direct, null); Common Stock — 24,531 shares (Direct, null)
Footnotes (1)
  1. The Reporting Person exercised a stock option to purchase 11,000 shares of the Issuer's Common Stock for $34.96 per share and paid the exercise price on a cashless basis, resulting in the Issuer withholding an aggregate of 4,661 shares of the Issuer's Common Stock subject to the stock option to pay the exercise price and to satisfy its income tax withholding and remittance obligations in connection with the exercise of the stock option. The withholding of shares referenced here does not involve an open market sale of stock. The Reporting Person exercised a stock option to purchase 18,368 shares of the Issuer's Common Stock for $49.39 per share and paid the exercise price on a cashless basis, resulting in the Issuer withholding an aggregate of 10,996 shares of the Issuer's Common Stock subject to the stock option to pay the exercise price and to satisfy its income tax withholding and remittance obligations in connection with the exercise of the stock option. The withholding of shares referenced here does not involve an open market sale of stock. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.00 to $81.64, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote to this Form 4. The option shares subject to this option shall vest and become exercisable in three equal annual installments, with 1/3 of the option shares vesting and becoming exercisable on May 20, 2026, and with the remaining option shares vesting and becoming exercisable in two equal annual installments thereafter. The option shares are fully vested.
Open-market sale 1 4,336 shares at $82.14 Common stock sale on June 15, 2026
Open-market sale 2 13,375 shares at $81.0385 Common stock sale on June 15, 2026
Total shares sold 17,711 shares Net open-market sales in this Form 4
Options exercised 29,368 shares Derivative exercises of common stock options
Strike price 1 $34.96 per share Stock option exercise price for 11,000 shares
Strike price 2 $49.39 per share Stock option exercise price for 18,368 shares
Tax-withheld shares 15,657 shares at $82.50 Shares withheld to cover exercise price and taxes
Direct holdings after one sale 9,531 shares Common shares held directly after a reported sale
open-market sale financial
"transaction_action shows an open-market sale of common stock shares"
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
tax-withholding disposition financial
"transaction_action is labeled as a tax-withholding disposition"
A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.
cashless basis financial
"paid the exercise price on a cashless basis, resulting in withholding"
An agreement executed on a cashless basis lets a holder convert or exercise a security (like options, warrants, or conversion rights) without paying money upfront; instead the holder receives a smaller number of shares equal in value to what the cash would have purchased. Think of trading a coupon for fewer slices of a cake rather than handing over cash for the full slice. For investors, it affects how much ownership and dilution occur and avoids immediate cash outlays.
stock option financial
"The Reporting Person exercised a stock option to purchase shares"
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
weighted average price financial
"The price reported in Column 4 is a weighted average price"
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Ashe Gena L

(Last)(First)(Middle)
3 GARRET MOUNTAIN PLAZA
SUITE 401

(Street)
WOODLAND PARK NEW JERSEY 07424

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Anterix Inc. [ ATEX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Legal Officer & Corp Sec
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/15/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock06/15/2026M11,000A$34.9624,531D
Common Stock06/15/2026M18,368A$49.3942,899D
Common Stock06/15/2026F4,661(1)D$82.538,238D
Common Stock06/15/2026F10,996(2)D$82.527,242D
Common Stock06/15/2026S13,375D$81.0385(3)13,867D
Common Stock06/15/2026S4,336D$82.149,531D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (Right to Buy)$34.9606/15/2026M11,000 (4)05/20/2035Common Stock11,000$042,491D
Stock Option (Right to Buy)$49.3906/15/2026M18,368 (5)05/17/2032Common Stock18,368$00D
Explanation of Responses:
1. The Reporting Person exercised a stock option to purchase 11,000 shares of the Issuer's Common Stock for $34.96 per share and paid the exercise price on a cashless basis, resulting in the Issuer withholding an aggregate of 4,661 shares of the Issuer's Common Stock subject to the stock option to pay the exercise price and to satisfy its income tax withholding and remittance obligations in connection with the exercise of the stock option. The withholding of shares referenced here does not involve an open market sale of stock.
2. The Reporting Person exercised a stock option to purchase 18,368 shares of the Issuer's Common Stock for $49.39 per share and paid the exercise price on a cashless basis, resulting in the Issuer withholding an aggregate of 10,996 shares of the Issuer's Common Stock subject to the stock option to pay the exercise price and to satisfy its income tax withholding and remittance obligations in connection with the exercise of the stock option. The withholding of shares referenced here does not involve an open market sale of stock.
3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.00 to $81.64, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote to this Form 4.
4. The option shares subject to this option shall vest and become exercisable in three equal annual installments, with 1/3 of the option shares vesting and becoming exercisable on May 20, 2026, and with the remaining option shares vesting and becoming exercisable in two equal annual installments thereafter.
5. The option shares are fully vested.
Remarks:
/s/ Gena L. Ashe06/17/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Anterix (ATEX) executive Gena Ashe do in this Form 4 filing?

Gena L. Ashe, Anterix’s Chief Legal Officer & Corporate Secretary, exercised stock options for common shares and reported related share dispositions, including tax-withholding transfers to the company and open‑market sales of Anterix common stock on June 15, 2026.

How many Anterix (ATEX) shares did Gena Ashe sell on June 15, 2026?

The Form 4 shows Gena Ashe completed open‑market sales of 17,711 Anterix common shares. These included 4,336 shares at about $82.14 each and 13,375 shares at a weighted average price of about $81.04 per share, according to the reported transaction details.

How many Anterix (ATEX) stock options did Gena Ashe exercise?

Gena Ashe exercised stock options covering a total of 29,368 Anterix common shares. This consisted of 11,000 shares at a $34.96 strike price and 18,368 shares at a $49.39 strike price, as disclosed in the transaction and footnote descriptions.

Were all Gena Ashe’s Anterix (ATEX) share dispositions open‑market sales?

No. The Form 4 states 15,657 shares were withheld by Anterix to pay option exercise prices and income tax obligations. Footnotes specify these tax-withholding dispositions did not involve open‑market stock sales, distinguishing them from the reported open‑market sale transactions.

What Anterix (ATEX) holdings remain for Gena Ashe after these transactions?

One reported open‑market sale left Gena Ashe with 9,531 Anterix common shares held directly. The filing’s line‑item totals show this post‑transaction balance for that sale; it does not aggregate additional ownership beyond the positions explicitly reported.

At what prices were Gena Ashe’s Anterix (ATEX) transactions executed?

The filing reports option exercises at strike prices of $34.96 and $49.39 per share. Open‑market sales occurred at weighted average prices around $81.04 and $82.14 per share, while 15,657 shares were withheld by Anterix at $82.50 per share for cashless exercise and taxes.